Daily Compliance News: March 24, 2025, The ABC Task Force Edition
JONES DAY TALKS®: International Litigation: Confidentiality and Legal Privilege under French Law
JONES DAY TALKS®: Private Antitrust Litigation in France
Compliance Perspectives: The French AFA on their Anti-Corruption Activities and Guidance ("Sapin 2 Law")
JONES DAY PRESENTS®: Trade Secret Enforcement in France
FCPA Compliance Report-Special Airbus Series-Cecilia Fellouse-Guenkel, the French Perspective
Podcast: Digital Taxation—Implications for EU Technology Companies
Everything Compliance-Episode 3
FCPA Compliance Report-Episode 293, Saskia Zandieh on the new French Anti-Corruption law, Sapin II
With industries embracing this evolving technology, Europe is determined not to be left behind, and dealmakers are paying close attention - Europe’s artificial intelligence industry is gaining traction but has struggled to...more
As recently reported by the Financial Times, the Stargate project is considering future investments into digital infrastructure in Europe, with consideration being given to data centre projects in each of the UK, France and...more
At a time of marked geopolitical uncertainty, governments around Europe are committing to meaningful increases in defence spending, whilst also looking to private capital and investment to supplement public funds. This in...more
As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and...more
Now in its seventh year of annual publication, White & Case's Foreign Direct Investment Reviews provides a comprehensive look into rapidly evolving foreign direct investment (FDI) laws and regulations in approximately 40...more
After an insightful conference in Cannes, our partners have compiled some of the key takeaways from IPEM 2022. As well as exploring the private equity landscape in the UK, Germany, France and Italy, we also explore the...more
Today’s global healthcare marketplace is marked by unprecedented transformation. The seismic shifts in healthcare delivery and drug development during COVID-19 have, in 2021, continued to demonstrate the power and capacity...more